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Wong et al. show that by producing
chemokines that recruit monocytes and
by upregulating NKG2D ligands that
activate ILCs, Langerhans cells are
responsible for the innate immune
cascade in the lymph node that is critical
for survival of infection with a
disseminating virus.
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During disseminating viral infections, a swift innate
immune response (IIR) in the draining lymph node
(dLN) that restricts systemic viral spread is critical
for optimal resistance to disease. However, it is un-
clear how this IIR is orchestrated. We show that after
footpad infection of mice with ectromelia virus, den-
dritic cells (DCs) highly expressing major histocom-
patibility complex class II (MHC class IIhi DCs),
including CD207+ epidermal Langerhans cells (LCs),
CD103+CD207+ double-positive dermal DCs (DP-
DCs), and CD103CD207 double-negative dermal
DCs (DN-DCs) migrate to the dLN from the skin car-
rying virus. MHC class IIhi DCs, predominantly LCs
and DP-DCs, are the first cells upregulating IIR cyto-
kines in the dLN. PreventingMHC class IIhi DCmigra-
tion or depletion of LCs, but not DP-DC deficiency,
suppresses the IIR in the dLN and results in high viral
lethality. Therefore, LCs are the architects of an early
IIR in the dLN that is critical for optimal resistance to
a disseminating viral infection.
INTRODUCTION
Numerous viruses relevant to human and animal health use a
lympho-hematogenous route of dissemination whereby they
penetrate their hosts though disruptions of epithelial surfaces
such as the skin, spread to the draining lymph nodes (dLNs)
via afferent lymphatics, and become systemic by disseminating
to the blood through efferent lymphatics (Flint et al., 2015). Yet,
our mechanistic understanding of how the innate immune
system of the host imposes protective barriers to the virus
during lympho-hematogenous dissemination is incomplete,
perhaps because few experimental models replicate this type
of spread.
One of the best models to study lympho-hematogenous
spread from the skin is ectromelia virus (ECTV), a member of
the Orthopoxvirus genus of large, closely related DNA viruses
and the causative agent of mousepox (themouse homolog of hu-
man smallpox). In fact, ECTV was the virus used to elucidate this
form of dissemination and is used as its archetype (Chapman
et al., 2010; Flint et al., 2015; Virgin, 2005). Following infection
through the skin of the footpad, ECTV disseminates lympho-
hematogenously, resulting in high mortality in naive mice of sus-
ceptible strains, such as BALB/c, B6.D2-(D6Mit149-D6Mit15)/
LusJ (B6.D2-D6) (Fang et al., 2011; Wallace and Buller, 1985;
Wallace et al., 1985). On the other hand, naive young wild-type
(WT) B6 mice and vaccinated BALB/c and B6.D2-D6 mice resist
the infection with almost no signs of disease (Sigal, 2016). Our
previous work using ECTV contributed to the now established
paradigm that lymph nodes (LNs) are not only the organs where
lymphocytes are primed before they egress to fight pathogens at
primary sites of infection, but are also critical sites where innate
and adaptive immune cells can restrict the spread of pathogens.
For example, we and others have shown that natural killer (NK)
cells in naive B6 mice (Fang et al., 2008; Jacoby et al., 1989;
Parker et al., 2007) and memory CD8+ T cells in CD8-immunized
BALB/c and B6.D2-D6 mice (Remakus et al., 2012; Xu et al.,
2007) curb ECTV spread from the popliteal dLNs to the spleen
and liver and protect from mousepox.
Others have further highlighted the importance of dLNs as re-
striction sites for pathogen dissemination, including subcapsu-
lar sinus macrophages limiting murine cytomegalovirus (MCMV)
spread (Farrell et al., 2016) as well herpes simplex virus 1
(HSV-1) spreading unchecked to the brain due to a loss in
dLN integrity (Conrady et al., 2010). Moreover, neutrophils are
actively recruited to dLNs to phagocytose Staphylococcus
aureus to prevent dissemination to blood and other organs (Bo-
goslowski et al., 2018). Furthermore, pathogens that can evade
immune surveillance in the dLN have downstream conse-
quences for the adaptive response. For example, the blue-
tongue virus in sheep increases dissemination by destroying
follicular dendritic cells (DCs) in the LN, thus impairing B cell
activation and antibody production (Melzi et al., 2016).
DCs, initially characterized for their expression of the integrin
CD11c, are professional antigen-presenting cells (APCs) that
are abundant in skin and other peripheral tissues, where they
are strategically positioned to function as immune sentinels
(Clausen and Stoitzner, 2015; Malissen et al., 2014). Skin
DCs are a heterogeneous group of major histocompatibility
complex class II (MHC class IIhi) cells that include epidermal
CD103CD207+ Langerhans cells (LCs), CD103+CD207+
double-positive dermal DCs (DP-DCs), which are part of
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the type 1 conventional DCs (cDC1), and CD103CD207 dou-
ble-negative dermal DCs (DN-DCs), which encompass the type
2 conventional DCs (cDC2) (Merad et al., 2008; Mildner and
Jung, 2014; Murphy, 2013). Numerous inflammation/infection
models, including contact hypersensitivity (Bennett et al.,
2007), HSV-1 (Lee et al., 2009), lentivirus (He and Falo, 2006),
leishmania (Moll et al., 1995), and C. albicans infection (Kashem
et al., 2015), have demonstrated that skin DC subsets migrate to
the dLN to prime T cell responses. In the case of footpad ECTV
infection, we have previously shown that CD11c+ cells intrinsi-
cally expressing TLR9 and MyD88 produce CCL2 and CCL7 to
recruit inflammatory monocytes (iMOs) to the dLN. At 60 h
post-infection (hpi), many of these iMOs are infected and are
themajor producers of interferon I (IFN-I) (Xu et al., 2015), an anti-
viral cytokine that is critical for resistance to mousepox (Jacoby
et al., 1989; Karupiah et al., 1993; Rubio et al., 2013; Xu et al.,
2008). However, because CD11c is expressed by not only DCs
but also other myeloid and lymphoid cells (Gordon and Taylor,
2005; Hume, 2008; Metlay et al., 1990), including iMOs, the spe-
cific CD11c+ cell responsible for iMO recruitment remained un-
known. Recently, we have shown that at 24 hpi with ECTV, a
population of DCs that express high levels of major histocompat-
ibility complex class II molecules (MHC class IIhi DCs) upregulate
NKG2D ligands to induce IFN-g in group 1 innate lymphoid cells
(G1-ILCs) already present in the dLN. This IFN-g induces CXCL9
in uninfected iMO to further recruit circulating NK cells to the dLN
which are critical for resistance to mousepox (Fang et al., 2011;
Wong et al., 2018). Together, these data suggested that MHC
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Figure 1. MHC Class IIhi DCs Mediate the
Early IIR in the dLN after ECTV Infection
(A–G) Mice were infected in the footpad with 3,000
PFU ECTV. Data show expression of Evm003 (A),
Ifna4 (B), Ifna-non4 (C), Ifnb1 (D), Mx1 (E), Ccl2 (F),
and Ccl7(G) in the specified sorted immune cell
populations present in the dLN at 24 hpi. Data are
displayed as mean ± SEM of pooled cells from six
mice per group in one experiment, which is repre-
sentative of two similar experiments. p values were
calculated based on three technical replicates.
For all, *p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001. A complete gating strategy for MHC
class IIhi DCs can be found in Figure S1.
immune response (IIR). However, whether
infected and/or uninfected MHC class
IIhi DCs migrate from the skin to the dLN
after footpad ECTV infection remained to
be demonstrated. More importantly, it re-
mained unknown which subset of infected
and/or uninfected skin DCsmay play a role
in orchestrating the IIR in the dLN, in the
control of virus spread, and in resistance
to viral disease. Here, we address these is-
sues by showing that three types of MHC
class IIhi DCs migrate to the dLN in
response to ECTV infection and that the
three MHC class IIhi DC subsets are func-
tionally distinct in terms of cytokine production, with DP-DCs
and LCs being much more pro-inflammatory than DN-DCs. We
also show that LCs, but not DP-DCs, are required for iMO and
NK cell recruitment to the dLN and their subsequent expression
of IFN-I and IFN-g. Moreover, we demonstrate that LCs but not
DP-DCs are critical for virus control and intrinsic resistance to
lethal mousepox.
RESULTS
MHCClass IIhi DCs Mediate the Early IIR in the dLN after
ECTV Infection
To further understand the role of MHC class IIhi DCs (also
CD45+CD11c+CD4CD8NK1.1CD64; Figure S1) in the initi-
ation of the IIR in the dLN, we infected B6 mice in the footpad
to mimic natural infection (3,000 plaque-forming units [PFUs] in
30 mL PBS) and sorted MHC class IIhi DCs and other immune
cell subsets (gating strategy for sorting shown in Figure S1)
present in the dLN at 24 hpi, isolated their RNA, and used
qRT-PCR to determine infection by measuring mRNA for the
ECTV gene evm003 and activation status by measuring
mRNA for IFN-I, the interferon-stimulated gene (ISG) Mx1,
and the chemokines Ccl2 and Ccl7, which are important for
iMO recruitment (Xu et al., 2015). The results showed that
MHC class IIhi DCs had significantly higher levels of all these
transcripts (Figures 1A–1G), suggesting that MHC class IIhi
DCs are the first to become infected and initiate the early anti-
viral IIR in the dLN, and they might be responsible for iMO
recruitment.
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MHC Class IIhi DCs Migrate from the Skin to the dLN in
Response to Infection
Compared to the contralateral non-draining LN (ndLN), the fre-
quency (Figure 2A) of MHC class IIhi DCs was significantly
increased in the dLN at 24 hpi, suggesting that infected MHC
class IIhi DCs are rapidly recruited into the dLN following viral
infection. According to kinetics analysis, their absolute
numbers significantly increased in the dLN at 24 h, peaked at
48 h, and decreased by 60 hpi (Figure 2B). Infection with
ECTV-dsRED revealed a significant fraction of MHC class IIhi
DCs were infected at 48 hpi, similar to what was observed in
iMOs (Figure 2C; et al., 2015). An analysis of the kinetics of
infection in the dLN revealed that compared to other immune
cell types, MHC class IIhi DCs are among the earliest cell types
infected (24 and 36 h) and are the highest infected at later time
points (60 h) (Figure 2D).
It was likely that these MHC class IIhi DCs migrated to the dLN
from the skin, because it is known that MHC class IIhi DCs from
the skin migrate to LNs at steady state and increase their migra-
tion during inflammation (Alvarez et al., 2008; Merad et al., 2008).
To test this directly, we illuminated the footpads of mice trans-
genic for ubiquitously expressed photoactivatable GFPs (Ubc-
PA-GFP mice; Victora et al., 2010) with a 415-nm light, and 4 h
later, we infected them or not with ECTV. Under these condi-
tions, any GFP+ cells present in the dLN at various times post-
infection should have been in the skin during illumination (Fig-
ure S2). At 48 hpi, GFP+ cells represented a large proportion of
the MHC class IIhi DCs in the dLN but were absent in other cell
populations (Figures 2E and S2). This demonstrates that MHC
class IIhi DCs, but not other cells, migrate from the skin to the
dLN in responses to ECTV infection. Kinetic analysis showed
that GFP+ MHC class IIhi DCs were detectable in dLNs at
24 hpi, peaked at 48 hpi, and decreased by 60 hpi (Figure 2F).
MHC Class IIhi DC Migration from the Skin to the dLN Is
Required for iMO and NK Cell Accumulation in the dLN
and Resistance to Lethal Viral Disease
It is well established that the migration of DCs to LNs requires
G-protein-coupled receptor signaling (Alvarez et al., 2008; Ti-
berio et al., 2018) and that pertussis toxin (PT) inhibits G-pro-
tein-coupled-receptor-dependent cell migration (Burns, 1988;
Karimian et al., 2012). To test whether the migration of MHC
class IIhi DCs from the skin of the footpad to the dLN is
required for antiviral defense, we administered PT directly
into the same footpad (PT + ECTV mice) 24 h before and after
ECTV and compared the IIR in their dLNs with the dLNs of
mice receiving only ECTV (ECTV mice). Significantly fewer
MHC class IIhi DCs accumulated in the dLN of PT + ECTV
mice compared to the dLN of ECTV mice. Indeed, the number
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Figure 2. MHC Class IIhi DCs Migrate from
the Skin to the dLN in Response to Infection
(A) Representative flow cytometry plots of gated
CD11c+MHC class IIhi DCs from the dLN at 24 hpi
(left) and a graph displaying the range of frequencies
are shown.
(B) Calculated number of MHC class IIhi DCs in the
dLNs at the indicated time points post infection.
Data are displayed as the mean ± SEM of eight
mice per group combined from two independent
experiments.
(C) Representative flow cytometry plot displaying
ECTV infected (dsRED+) and uninfected (dsRED)
MHC class IIhi DCs at 48 hpi.
(D) Graph depicting the kinetics of infected
(dsRED+) cells in different immune cell populations.
Data are displayed as the mean ± SEM of 12–14
mice per group combined from three independent
experiments.
(E) Representative flow cytometry of different im-
mune cell populations showing GFP+ gates at 48 hpi
in dLNs from Ubc-PA-GFP mice that had been illu-
minated in the footpad with a 415-nm light 4 h
before infection.
(F) Graph depicting the total number of GFP+ MHC
class IIhi DCs at different time points in the indicated
LNs of Ubc-PA-GFP mice whose feet had had been
illuminated (illum) or not 4 h before infection. Addi-
tional controls for Ubc-PA-GFP mice are shown in
Figure S2. p values are compared to non-illumi-
nated ndLNs. Additional controls for Ubc-PA-GFP
mice are shown in Figure S2. Data are displayed as
the mean ± SEM of 12 mice per group combined
from three independent experiments.
For all, *p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001.
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Figure 3. MHC Class IIhi DCMigration from the Skin to the dLN Is Required for iMO and NK Cell Accumulation and Resistance to Lethal Viral
Disease
(A) Representative flow cytometry plots of MHC class IIhi DC frequency in the dLNs at 48 hpi with or without localized pertussis toxin (PT) administration in the
footpad 24 h before and after infection.
(B) Calculated number of MHC class IIhi DCs from the dLNs of PT-treated mice at 48 hpi.
(legend continued on next page)
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statistically different than those in the ndLNs of ECTV mice and
dLNs of control mice that received only PT (Figures 3A and
3B). The decreased accumulation of MHC class IIhi DCs in
the dLN of PT + ECTV mice was not due to a systemic effect
of PT, because when PT and ECTV were administered in the
right foot and only ECTV in the left foot, MHC class IIhi DC
accumulation was curtailed in the right dLN, but not in the
left dLN (Figure S3). Compared to ECTV mice, the dLN of
PT + ECTV mice also had significantly decreased transcription
of Ccl2 (Figure 3C) and Ccl7 (Figure 3D), which are required for
iMO recruitment, significantly diminished iMO accumulation
(Figures 3E and 3F) and significantly reduced transcription of
all IFN-I subtypes (Figures 3G–3I). Furthermore, PT + ECTV
mice had significantly diminished frequency (Figure 3J) and
total numbers (Figure 3K) of NK cells and consequently
significantly decreased levels of IFN-g expression in the dLN
(Figure 3L). Notably, while PT + ECTV mice transcribed signif-
icantly less viral RNA in the dLN at 2 dpi than ECTV mice (Fig-
ure 3M), viral loads at 7 dpi in the spleen (Figure 3N) and liver
(Figure 3O) were significantly higher in PT + ECTV mice than in
ECTV mice. Moreover, even though B6 mice are naturally
resistant to lethal mousepox, a significant proportion of PT +
ECTV mice succumbed to the infection (Figure 3P). These
data indicate that G-protein-coupled-receptor-dependent
MHC class IIhi DC migration to the dLN plays a crucial role in
the early transport of ECTV to the dLN and that this process
is crucial for protective innate immunity in the dLN and resis-
tance to viral disease.
The ThreeMajor Subsets of Skin DCsMigrate to the dLN
in Response to ECTV Infection
We next compared the effects of ECTV infection in the three
subsets of skin-derived MHC class IIhi DCs in the dLN: LCs
(CD103CD207+), DP-DCs (CD103+CD207+), and DN-DCs
(CD103CD207). The frequency of DN-DCs andDP-DCs signif-
icantly increased while LC frequency concomitantly decreased
after infection at 48 h (Figures 4A and 4B). However, the total
numbers of the three skin-DC subsets in the dLN were signifi-
cantly increased at 48 hpi (Figure 4C). A kinetics analysis using
Ubc-PA-GFP mice demonstrated that the three DC subsets fol-
lowed a similar rate of migration, initially arriving to the dLN at
24 hpi, peaking at 48 hpi, and precipitously dropping by 60 hpi
(Figures 4D and S4). Infection with ECTV-dsRED revealed a dif-
ferential rate of infection among the DC subsets, with DP-DCs
having the highest frequency of infected cells (Figures 4E and
S4). Moreover, while a considerable fraction of GFP+ cells of
the three MHC class IIhi subsets were infected (dsRED+), many
were uninfected (dsRED) at all times tested (Figure 4E). This
suggests that viral-induced inflammation promotes the migra-
tion to the dLN of infected and also noninfected cells of the three
skin-derived MHC class IIhi DC subsets. Furthermore, infected,
but not uninfected, MHC class IIhi DCs significantly upregulated
NKG2D ligand MULT-1 expression, indicating that all three sub-
sets are capable ofmediating the early IFN-g response from ILCs
in the LN (Figures 4F and 4G).
MHC Class IIhi DC Subsets Respond Differently to Viral
Infection
Next, we investigated whether the three subsets of MHC class
IIhi DCs have similar or distinct cytokine profiles in response to
infection and whether this is affected by their infection status.
With this purpose, we infected B6 mice with ECTV-dsRED;
sorted infected (dsRED+) and uninfected (dsRED) DN-DCs,
DP-DCs, and LCs from the dLN; and quantified transcripts for
the viral gene Evm003, IFN-Is, and various cytokines and che-
mokines. As expected, dsRED+MHCclass IIhi of all subsets tran-
scribed significantly higher amounts of viral RNA than their
dsRED counterparts, yet DN-DCs transcribed significantly
more viral RNA than LCs and DP-DCs (Figure 5A). Conversely,
compared to DN-DCs, infected DP-DCs and LCs transcribed
higher levels of mRNA for most cytokines and chemokines,
including Ccl2 (Figure 5B), which is required for the recruitment
of iMOs. An exception was Ccl7, also required for iMO recruit-
ment, whose mRNA was transcribed highest by uninfected
DP-DCs (Figure 5C). Cxcl9 was transcribed mostly by infected
cells (Figure 5D). Other cytokine/chemokine mRNAs varied in
the level of transcription between MHC class IIhi subsets with in-
fected DP-DCs and LCs expressing high levels of mRNA forCcl8
(also in uninfected DP-DCs), Ccl19 (also in uninfected LCs), Il1b
(also in uninfected LCs), ll6, Il17, Il18, and Tnf (Figures 5E–5K). In
the case of IFN-I mRNA, Ifnb1 (Figure 5L), Ifna4 (Figure 5M), and
Ifna-non4 (Figure 5N) were upregulated by the three subsets of
infected DCs to different levels, while the cells that mostly upre-
gulated Ifna-non4 were uninfected DP-DCs.
(C and D) Expression ofCcl2 (C) andCcl7 (D) in the dLNs of the indicated mice at 48 hpi as determined by qRT-PCR. Data are displayed asmean ± SEM from four
to six mice per group in one experiment, which is representative of three similar experiments.
(E) Representative flow cytometry plots of iMOs in the dLN at 48 hpi.
(F) Calculated numbers of iMOs in the dLN at 48 hpi. Data are displayed as the mean ± SEM of five to nine mice per group combined from three independent
experiments.
(G–I) As in (C) and (D), but measuring RNA for Ifna4 (G), Ifna-non4 (H), and Ifnb1 (I). Data are displayed as mean ± SEM from five to eight mice per group in one
experiment, which is representative of two similar experiments.
(J) Representative flow cytometry plots of NK cells in the dLNs at 48 hpi.
(K) Calculated numbers of NK cells in the dLN at 48 hpi. Data are displayed as the mean ± SEM of five to nine mice per group combined from three independent
experiments.
(L andM) As in (C) and (D) but measuring IFN-g (L) and Evm003 (M). Data are displayed asmean ± SEM from four to six 6mice per group in one experiment, which
is representative of three similar experiments.
(N and O) Virus loads in the spleen (N) and livers (O) of the indicated mice at 7 dpi as determined by plaque assay. Data are displayed as the mean ± SEM of five
mice per group.
(P) Survival of indicated mice.
For all, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. Additional controls for the effects of PT inoculation are depicted in Figure S3.
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LCs, but Not DP-DCs, Are Required for Optimal
Resistance to ECTV Infection
Given their different functionality and highly induced proinflam-
matory cytokine profiles, we next investigated whether DP-
DCs and/or LCs are required for the early IIR in the dLN and
resistance to lethal mousepox. We tested the role of DP-DCs us-
ing Batf3/ mice, which lack DP-dermal DCs and also LN resi-
dent CD8a+ DCs (Hildner et al., 2008). Compared toWTB6mice,
Batf3/ mice infected with ECTV had no significant differences
in the frequency of total MHC class IIhi DCs (Figure 6A) but had a
significant reduction in DP-DCs in the dLN, while DN-DCs and
LCs were not affected (Figure 6B). The lack of DP-DCs did not
affect the overall transcription levels of Ccl2 (Figure 6C) or Ccl7
(Figure 6D), the accumulation of iMOs (Figure 6E), or the subse-
quent transcription of IFN-I genes (Figure 6F–6H) in the dLN.
Similarly, the frequency of NK cells (Figure 6I) and IFN-g mRNA
in the dLN (Figure 6J) of Batf3/ mice did not differ compared
to B6 mice. Moreover, WT B6 and Batf3/ mice had compara-
ble levels of viral RNA transcription in the dLN at 48 hpi (Fig-
ure 6K) and no significant differences in viral loads at 7 dpi in
both the spleen (Figure 6L) and liver (Figure 6M), and they were
fully resistant to lethal mousepox (Figure 6N).
Next, we determined the role of LCs using mice transgenic for
the human diphtheria toxin (DT) receptor driven by the human
langerin (CD207) promoter (CD207-DTR mice, herein DTR+),
wherein administration of DT results in ablation of LCs, but not
DP-DCs (Bobr et al., 2010; Kaplan, 2010; Kaplan et al., 2005).
As expected, administration of DT to DTR+ mice, but not to
DTR littermate controls, significantly decreased the accumula-
tion of LCs (Figure 7A) but not of DN-DCs (Figure 7B) or DP-DCs
(Figure 7C) in the dLN following ECTV infection. Furthermore, DT























































































































































Figure 4. The Three Major Subsets of Skin DCs Migrate to the dLN in Response to ECTV Infection
(A) Gating strategy and representative flow cytometry plots for MHC class IIhi DC subsets at 48 hpi.
(B and C) Graph depicting the frequency (B) and calculated total numbers (C) of MHC class IIhi DC subsets in the dLNs at 48 hpi. An additional gating strategy is
depicted in Figure S4. Data are displayed as mean ± SEM from 12–14 mice per group, combined from three similar independent experiments.
(D) Graph depicting the calculated total number of GFP + MHC class IIhi DCs at the indicated time points in the dLNs of Ubc-PA-GFP mice whose feet had been
illuminated 4 h before infection. Data are displayed as mean ± SEM from 10 mice per group, combined from two similar independent experiments.
(E) Graph depicting the frequency of ECTV-dsRED+GFP+MHC class IIhi DC subsets at the indicated time points in the dLN of the mice in (D). Data, displayed as
mean ± SEM, correspond to 15 mice per group, combined from three similar independent experiments. Complete gating strategies are depicted in Figure S4.
(F and G) Representative histograms (F) and graph (G) depicting the MFI of NKG2D ligand Mult1 in MHC class IIhi DC subsets. Data, displayed as mean ± SEM,
correspond to 10 mice per group, combined from two similar independent experiments.
For all, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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decreased the transcription of Ccl2 (Figure 7D) and Ccl7 (Fig-
ure 7E), and, likely as a consequence, the accumulation of
iMOs (Figure 7F) and reduced IFN-I expression levels in the
dLN (Figure 7G). Moreover, DTR+ mice, but not DTR mice,
had a significant reduction in total NK cell numbers (Figure 7H)
and IFN-g expression in the dLN (Figure 7I). Furthermore,
DTR+ mice, but not DTR mice, had a significant increase in viral
RNA transcription in the dLN at 2 dpi (Figure 7J), significantly
increased virus loads in the spleen (Figure 7K) and liver (Fig-
ure 7L) at 7 dpi, and significant mortality following ECTV infection
(Figure 7M). Together, these data demonstrate that LCs, but not
DP-DCs, are important for the CCL2/CCL7-dependent accumu-
lation of iMOs that primarily mediates the IFN-I response, as well
as facilitating NK cell accumulation and subsequent IFN-g
response in the dLN. Ultimately, this LC-mediated IIR is critical
for optimal virus control and survival to mousepox.
DISCUSSION
We have previously shown that a highly choreographed IIR in the
dLN is critical to curb systemic viral dissemination and resistance
to mousepox through the antiviral functions of IFN-I and NK cells
(Fang et al., 2011; 2008; Wong et al., 2018; Xu et al., 2015). In
particular, we showed that after infection of the footpad with
ECTV, CD11c+ cells (most likely DCs) are required for







































































































































































































































































































































































































Figure 5. MHC Class IIhi DC Subsets Respond Differently to Viral Infection
(A–N) Expression of mRNA for EVM003 (A), the chemokinesCcl2 (B), Ccl7 (C),Cxcl9 (D),Ccl8 (E), and Ccl19 (F); the inflammatory cytokines Il1b (G), Il6 (H), Il17 (I),
Il18 (J), and Tnf (K); and the IFN-I subtypes Ifnb1 (L), Ifna4 (M), and Ifna-non4 (N), in the different MHC class IIhi DC subsets distinguished by infection status in the
dLN at 48 hpi. Data are displayed asmean ± SEM of pooled cells from eight mice per group in one experiment, which is representative of two similar experiments.
p values were calculated based on three technical replicates. For all, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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(Xu et al., 2015) and that MHC class IIhi DCs in the dLN, which are
presumably skin derived (Malissen et al., 2014; Merad et al.,
2008, 2013), upregulate the expression of NKG2D ligands to
stimulate the production of IFN-g in NK cells already in the dLN
at the time of infection (Wong et al., 2018). The consequence of
these processes, both requiring intrinsic TLR9/MyD88 in
CD11c+ cells, is that infected iMOs produce IFN-I (Xu et al.,
2015) and uninfected iMOs responding to IFN-g produce
CXCL9 to recruit circulating NK cells (Wong et al., 2018; Xu
et al., 2015). We now show that as early as 24 hpi, MHC class
IIhi DCs express 10-fold more ECTV transcripts than any other
cell type in thedLN, suggesting that theyare the first cells infected
in the dLN. Concordantly, MHC class IIhi DCs expressmore tran-
scripts for IFN-I and the ISG MX1, suggesting that they are the
first cells that sense viral infection. Moreover, compared to other
cell types, MHC class IIhi DCs express significantly more tran-
scripts for CCL2 and CCL7. This suggests that MHC class IIhi
DCs are the CD11c+ cells responsible for the recruitment of
iMOs to the dLN and that in addition to their role in promoting
adaptive immune responses through antigen presentation (Allan
et al., 2006;Bedoui andGreyer, 2014;Helft et al., 2012;Waithman
et al., 2013), MHC class IIhi DCs also play a pivotal role at assem-
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Figure 6. DP-DCs Are Not Required for an
Efficient IIR in the dLN or Resistance to Le-
thal Mousepox
(A) Representative flow cytometry plots of MHC
class IIhi DC frequency in the dLNs at 48 hpi in
Batf/ mice.
(B) Total number of DN-DCs, DP-DCs, and LCs in
the dLNs of B6 and Batf/ mice at 48 hpi.
(C and D) Expression of Ccl2 (C) and Ccl7 (D) in the
dLNs at 48 hpi as determined by qRT-PCR. Data
are displayed as mean ± SEM from five to seven
mice per group in one experiment, which is repre-
sentative of three similar experiments.
(E) Frequency of iMOs in the dLNs of B6 andBatf/
mice 48 hpi.
(F–H) As in (C) and (D), but measuring expression of
the IFN-I subtypes Ifna4 (F), Ifna-non4 (G), and Ifnb1
(H) in the dLN at 48 hpi.
(I) Frequency of NK cells in the dLNs of B6 and
Batf/ mice 48 hpi.
(J and K) Expression of IFN-g (J) and Evm036 (K) in
the dLN at 48 hpi as determined by qRT-PCR. Data
are displayed as mean ± SEM from five to eight
mice per group in one experiment, which is repre-
sentative of three similar experiments.
(L and M) Virus loads in the spleen (L) and livers (M)
of the indicated mice at 7 dpi as determined by
plaque assay.
(N) Survival of the indicated mice.
For all, *p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001.
ings in other viral models of footpad infec-
tion, where the first cells to become
infected are subcapsular macrophages.
Perhaps the difference is that because
ECTV is a mouse pathogen that normally
spreads from abrasions of the skin, we can use doses of only
3,000 PFU of virus, while other systems, including vesicular
stomatitis virus (VSV) (Iannacone et al., 2010; Junt et al., 2007),
modified vaccinia Ankara (MVA) (Garcia et al., 2012), and
MCMV (Farrell et al., 2015), use doses of 106 to 5 3 106 PFUs,
which may directly push viral particles into the LN bypassing
the need for skin infection.
It is well established that skin DCs constitutivelymigrate to LNs,
where they are detected as MHC class IIhi DCs, and that their
migration is increasedduring inflammation (ClausenandStoitzner,
2015; Malissen et al., 2014; Merad et al., 2013, 2008). However,
whether ECTV infection in the footpad increases skinDCmigration
was not known. We found the frequency and total numbers of
MHC class IIhi DCs in the dLN significantly increased starting at
24 hpi. Peak accumulation occurred at 48 hpi, which preceded
the peak of iMO accumulation (60 hpi) (Xu et al., 2015), and then
precipitously dropped in total numbers, leaving a large proportion
of those remaining infected. This outcome suggests that the steep
decline in MHC class IIhi DCs might be due to ECTV-induced cell
death or their killing by iMOs or NK cells. Footpad illumination of
Ubc-PA-EGFP transgenic mice (Victora et al., 2010) definitively
confirmed that MHC class IIhi DCs migrate from the footpad to
the dLN and that they are the only cell type that do so.
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The mechanisms and importance of MHC class IIhi DC migra-
tion from the skin to the dLN in virus control were revealed
through the administration of PT in the footpad to block immune
cell migration (Burns, 1988; Karimian et al., 2012). One caveat is
that localized PT treatment in the footpad blocks all chemokine-
dependent immune cell migration from the skin to the dLN; how-
ever, the data from the Ubc-PA-GFPmice indicate that it is over-
whelmingly MHC class IIhi DCs that are traveling to the dLN after
infection. PT-treated B6 mice had highly reduced accumulation
of MHC class IIhi DCs in the dLN and had significantly reduced
transcripts for the monocyte-recruiting chemokines CCL2 and
























































































































































































































































































































































































































































Figure 7. LCs Are Required for the Recruitment of iMOs to the dLN and Optimal Resistance to Lethal Mousepox
(A–C) Calculated numbers of LCs (A), DN-DCs (B), and DP-DCs (C) in the dLNs of DTR+ mice and their littermate controls at 48 hpi and after prior DT treatment.
(D and E) Expression ofCcl2 (D) andCcl7 (E) in the dLNs at 48 hpi as determined by qRT-PCR. Data are displayed asmean ± SEM from five mice per group in one
experiment, which is representative of three similar experiments.
(F) Calculated number of iMOs in the dLN of the indicated mice at 48 hpi and after prior DT treatment.
(G) As in (D) and (E) but measuring Ifnb1.
(H) Calculated number of NK cells in the dLN of the indicated mice at 48 hpi and after prior DT treatment.
(I and J) As in (D) and (E) but measuring IFN-g (I) and Evm003 (J).
(K and L) Virus loads in the spleen (K) and liver (L) of the indicated mice at 7 dpi as determined by plaque assay.
(M) Survival of the indicated mice.
For all, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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iMOs and decreased IFN-I transcripts in the dLN at 60 hpi. PT-
treated mice also had significantly lower numbers of NK cells
and reduced IFN-g expression in the dLN, all of which resulted
in increased viral loads in liver and spleen at 7 dpi, and high
lethality. Paradoxically, at 2 dpi, viral transcripts in the dLNs of
PT treated mice were significantly reduced. This suggests that
at least the initial transport of virus to the dLN is mediated by
MHC class IIhi DCs and that this is important to expedite the in-
duction of a protective IIR.
When we identified the subpopulations of MHC class IIhi DCs
as epidermal LCs, dermal DN-DCs, and DP-DCs, we found that
they all migrate from the footpad to the dLN at equivalent rates.
This is in contrast to previous studies that showed LCs lagging
behind in their movement to the dLN after activation due to
longer detachment times from keratinocytes (Fukunaga et al.,
2008; Kissenpfennig et al., 2005; Stoitzner et al., 2002; West
and Bennett, 2018). However, these studies utilized mechanical
disruption of the skin or topical agents to induce inflammation
and the migratory kinetics may differ from a viral infection,
possibly due to activation of different sensing pathways. Of
note, at all times, the three cell types differed in infection fre-
quencies, with DP-DCs being the most infected, followed by
LCs; the frequency of infected DN-DCs was relatively low.
Furthermore, all three DC subsets upregulate Mult1 when in-
fected, with DN-DCs and LCs expressing the highest levels, indi-
cating their potential to induce IFN-g from NK cells and ILCs
already in the LN to recruit iMOs (Wong et al., 2018).
Broadly, the different MHC class IIhi subsets vary in their
intrinsic and bystander response to infection, as determined by
their expression of various genes, in the following ways: (1) In-
fected DN-DCs produce the most viral transcripts but lag behind
LCs and DP-DCs in cytokine transcripts, except for Ccl8 and
Cxcl9, which they highly upregulate; (2) DN-DCs do not respond
as bystanders, at least for the genes that we tested; (3) infected
DP-DCs and LCs had a very proinflammatory profile, expressing
high levels of Il1b, ll6, Il17, Il18, and Tnf mRNA (in general, these
cells also transcribed various IFN-I genes and most of the che-
mokines genes tested); and (4) bystander DP-DCs and LCs in
general responded less than their infected counterparts, with
the exception that uninfected DP-DCs transcribed Ccl7 and
Ifna-non4 very highly and uninfected LCs were as efficient as
their infected counterparts at transcribing Ccl19 and Il1b. Impor-
tant to note, irrespective of their infection status, DP-DCs and
LCs, but not DN-DCs, expressed mRNA for CCL2 and CCL7,
which are necessary for iMO recruitment.
The finding that whether infected or bystander, MHC class IIhi
DC subsets respond very differently is intriguing. Moreover,
there are also interesting differences between iMO and MHC
class IIhi DCs. For example, we have previously shown that
bystander, but not infected, iMOs are major producers of
Cxcl9 (Wong et al., 2018), while here, we show that Cxcl9 is ex-
pressed by infected, but not bystander, MHC class IIhi DCs. Also,
we have shown that infected iMOs transcribe more RNA for all
subtypes of IFN-I than uninfected iMOs and that the signaling
pathway requires STING and IRF7 (Xu et al., 2015). While this re-
mained true for Ifnb1 and Ifna4 in DP-DCs and LCs and also for
Ifna-non4 in DN-DCs and LCs, the cells that mostly upregulated
Ifna-non4 were uninfected DP-DCs. This finding suggests that
DP-DCsmay use an alternative signaling mechanism to produce
IFN-I non-a4, perhaps one that depends on TLR9 and MyD88.
Together, this suggests that in vivo, the response to direct and
bystander infection varies highly between cell types, which
may be important for antiviral defense. RNA sequencing (RNA-
seq) experiments could expand this finding and reveal clues
about these cell-intrinsic roles depending on infection status.
Batf3/ mice mounted an IIR that was similar to B6 controls
and, as previously shown by others (Kaminsky et al., 2015),
were fully resistant to mousepox. Of note, DP-DCs and also
Batf3-depedent CD8a+ DCs are known to be the cells that
cross-present peptide on MHC class I to CD8 T cells in LNs (De-
sai et al., 2018; Henri et al., 2010; Hildner et al., 2008; Torti et al.,
2011). While the emphasis of this paper is focused on identifying
the MHC class IIhi DC subset(s) required to initiate the early IIR in
the dLN, it is important to mention that CD8+ T cells are essential
for resistance to mousepox (Fang and Sigal, 2005), which raises
the question of how CD8 T cells are initiated in Batf3/ mice.
Yet, we have also previously shown that cross-presentation is
dispensable for the CD8 T cell response to vaccinia virus (Xu
et al., 2010), which is highly related to ECTV. Moreover, others
have shown that during ECTV infection, the majority of pep-
tide-MHC class I is presented by infected cells, and thatBatf3/
mice mount normal CD8 T cell responses to ECTV (Kaminsky
et al., 2015; Sei et al., 2015) strongly suggesting that direct and
not cross-presentation is also the main mechanism of CD8
T cell priming during ECTV infection. One possible caveat with
Batf3/ mice is that interleukin-12 (IL-12) can restore DP DCs
(Tussiwand et al., 2012) and IL-12 is modestly induced during
ECTV infection. Yet, recovery of DP-DCs is unlikely to explain
our results, because we demonstrated the absence of DP-DCs
in Batf3/ mice at the times when IIRs were normal.
A significant result of our study is the finding that LCs, but not
DP-DCs, are required for optimal IIRs in the dLN and resistance
to mousepox. These results expand our previous study showing
that CCL2 and CCL7 produced by CD11c+ cells are primarily
responsible for the recruitment of iMOs to the dLN and the sub-
sequent IFN-I response (Xu et al., 2015). Even though both DP-
DCs and LCs showed significantly high levels of proinflammatory
cytokine profiles, particularly for CCL2 andCCL7, our data in DT-
treated DTR+ mice demonstrated a reduction after specific
depletion of LCs, while the total numbers of DN- and DP-DCs re-
mained unchanged. Perhaps this is just because more LCs than
DP-DCs migrate to the dLN following ECTV infection. LCs are
well known for their superior ability to prime the adaptive immune
response, as decades of research have demonstrated their abil-
ity to prime CD8+ T cells (Clausen and Stoitzner, 2015; Doebel
et al., 2017; Kaplan, 2010; Merad et al., 2008), and for their
importance in CD4+ T follicular helper cell activation in germinal
center reactions, which are necessary for high-affinity antibody
responses (Zimara et al., 2014). It is also known that LCs are
important as APCs for skin-resident T cells and the recruitment
of other immune cells, such as NK cells to the skin (West and
Bennett, 2018). Our new study demonstrates that LCs also
play a key role in the recruitment of iMOs and NK cells to the
dLN in response to infection and optimal intrinsic resistance to
a highly lethal viral disease. This study complements our previ-
ous work showing that infected skin-derived DCs activate NK
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cells and ILC1s already present in the dLN through NKG2D to
produce the early IFN-g that recruited iMOs need to secrete
CXCL9 to recruit circulating NK cells through CXCR3 (Wong
et al., 2018). Our data show that LCs have high expression of
theNKG2D ligandMULT1 andmay be the critical subset inmedi-
ating the early source of NKG2D-induced IFN-g. Future studies
should focus on identifying the signaling pathways that trigger
the recruitment of MHC class IIhi DCs from the skin to the dLN,
as well as on elucidating the other roles that MHC class IIhi
DCs play in the early immune response in the dLN. Overall, our
study highlights the critical role thatMHC class IIhi DCs in general
and LCs in particular play in the dLN as the architects of the early
IIR to a lethal viral infection.
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LEAD CONTACT AND MATERIALS AVAILABILITY
This study did not generate new unique reagents. Further information and/or requests for resources and reagents should be directed
to and will be fulfilled by the Lead Contact, Luis Sigal (luis.sigal@jefferson.edu).
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
BV785-CD3ε (Clone 145-2C11) Biolegend Cat#100302; RRID: AB_312667
BV711-CD8a (Clone 53-6.7) Biolegend Cat#100759; RRID: AB_2563510
APC/Cy7-CD11b (Clone M1/70) Biolegend Cat#101226; RRID: AB_830642
BV-421-Gr-1 (Clone RB6-8C5) Biolegend Cat#108433; RRID: AB_10900232
PE/Cy7-CD11c (Clone N418) Biolegend Cat#117317; RRID: AB_493569
FITC-CD45 (Clone I3/2.3) Biolegend Cat#147709; RRID: AB_2563541
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PerCP/Cy5.5-CD103 (Clone 2E7) Biolegend Cat#121416; RRID: AB_2128621
APC-CD207 (Clone 4C7) Biolegend Cat#144205; RRID: AB_2561997
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BUV395-CD4 (Clone GK1.5) BD Biosciences Cat#563790; RRID not available
BUV395-CD19 (Clone 1D3) BD Biosciences Cat#563557; RRID not available
Virus Strains
Ectromelia virus Moscow strain ATCC Cat#VR-1374
Chemicals, Peptides, and Recombinant Proteins
Pertussis toxin from Bortedella pertussis Sigma Cat#P7208
Diphtheria toxin derived from Corynebacterium diphtheriae EMD Millipore Cat#322326
Critical Commercial Assays
RNeasy Mini Kit QIAGEN Cat#74104
High Capacity cDNA Reverse Transcription Kit Thermo Fisher Cat#4368814
iTaq Universal SYBR Green supermix BioRad Cat#1725124
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Experimental Models: Organisms/Strains
C57BL/6N (B6) Charles River Cat#027
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Rockefeller University
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All the procedures involvingmice were carried out in strict accordance with the recommendations in the Eight Edition of the Guide for
the Care and Use of Laboratory Animals of the National Research Council of the National Academies. All protocols were approved by
Thomas Jefferson University’s Institutional Animal Care and Use Committee. All mice used in experiments were 6-12 weeks old and
males and females were both used. Colonies were bred at Thomas Jefferson University under specific pathogen free conditions. An-
imalswere housed in a controlled environment with 12-hour day/night cycle with optimal temperature and fed rodent chow ad libitum.
C57BL/6 (B6) mice were purchased from Charles River. B6.129S(C)-Batf3tm1Kmm/J (Batf3/) mice were purchased from Jackson
Laboratories. Breeder mice expressing photoactivatable green fluorescence protein under the mouse Ubiquitin C promoter (Ubc-
PA-GFP mice) were a gift from Dr. Gabriel Victora (Rockefeller University, New York, NY). Breeder mice expressing the human
diphtheria toxin receptor under the human Langerin (CD207) promoter (CD207-DTR mice) mice were a gift from Dr. Daniel Kaplan
(University of Pittsburgh, Pittsburg, PA).
METHOD DETAILS
Viruses and Infection
Virus stocks, including ECTV-Moscow strain (ATCC VR-1374), ECTV-EGFP (Fang et al., 2008), and ECTV-dsRED (Roscoe et al.,
2012) were propagated in tissue culture as previously described (Xu et al., 2008). Briefly, new stocks were expanded by infecting
BALB/c mice with 3000 PFU of ECTV in the footpad. Seven days p.i., the spleen and liver were removed and homogenized in
20 mL of RPMI using a tissue homogenizer. The solid material was pelleted by centrifugation, and the supernatant was stored in al-
iquots at80C. Virus titers in ECTV stocks were determined by plaque assays on BSC-1 cells. Briefly, 10-fold serial dilutions of the
stocks in 0.5 mL of RPMI 2.5 were used to infect confluent BSC-1 cells in 6-well plates (2 wells/dilution) for 1 h. Two milliliters of fresh
RPMI 2.5 were then added, and the cells were incubated at 37C for 5 days. After this time, the medium was aspirated and the cells
fixed and stained for 10 min with 0.1% crystal violet and 20% ethanol in water. The fix/stain solution was subsequently aspirated, the
cells air-dried, the plaques counted, and the PFU per milliliter in stocks were calculated accordingly.
Mice were infected in the footpad with 3,000 plaque forming units (PFUs) ECTV (ECTV-WT, ECTV-dsRED, or ECTV-EGFP) in 30 mL
PBS using a 1 mL syringe and a 27 g needle. For the determination of survival, mice were monitored daily for signs of disease (leth-
argy, weight loss, skin rash, ruffled hair, and eye secretions) and to avoid unnecessary suffering, mice were euthanized and counted
as dead when imminent death was certain as determined by lack of activity and unresponsiveness to touch. Euthanasia was accord-
ing to the 2013 edition of the AVMA Guideline for the Euthanasia of Animals.
For virus titers, the entire spleen or portions of the liver were homogenized in RPMI using a Tissue Lyser (QIAGEN). Virus titers were
determined on BSC-1 cells as before (Xu et al., 2008). Briefly, infected spleens and livers were prepared as single-cell suspensions
through disruption between two frosted glass slides. 10-fold serial dilutions of the stocks in 0.5 mL of RPMI 2.5 were used to infect
confluent BSC-1 cells in 24-well plates for 2 h. The supernatant was aspirated followed by the addition of 500 ml of carboxymethyl
cellulose, and the cells were incubated at 37C for 5 days. After this time, the medium was aspirated and the cells fixed with 5%
formaldehyde and stained for 10min with 0.1% crystal violet and 20% ethanol in water. The fix/stain solution was subsequently aspi-
rated, the cells air-dried, the plaques counted, and the PFU per milliliter in stocks were calculated accordingly.
Injections and Cell Depletions
To block themigration of skin-derived cells from the footpad to dLN, B6micewere injectedwith 200 ng of pertussis toxin derived from
Bordetella pertussis (Sigma) or control PBS in the footpad 1 d before and 1 d after infection with ECTV. To deplete LCs, CD207-DTR
mice were injected IP with 500 ng of diphtheria toxin derived from Corynebacterium diphtheriae (EMD Millipore) 1 d before and 1 d
after infection with ECTV. Efficient depletion of Langerhans cells was confirmed by flow cytometry using mAbs CD11c, MHC-II,
CD103 and CD207 in the LN at 1 d after the second depletion.
Flow Cytometry
Flow cytometry was performed as previously described (Xu et al., 2008). To obtain single-cell suspensions, LNs were first incubated
in Liberase TM (1.67W€unsch units/mL) (Sigma) in PBSwith 25mMHEPES for 30min at 37Cbefore adding PBSwith 25mMHEPES+
10% FBS to halt the digestion process, followed by mechanical disruption of the tissue through a 70-mm filter. Cells were washed
once with FACS buffer (PBS with 1% BSA + 0.1% sodium azide) before surface staining. For analysis, samples were acquired using
either a BD LSR II flow cytometer or a BD Fortessa flow cytometer (BD Biosciences), and data were analyzed with FlowJo software
(TreeStar). For cell sorting, samples were acquired with a BD FACS Aria III sorter (BD Bioscience).
Illumination of Ubc-PA-GFP Mice
Ubc-PA-GFP mice were anesthetized with 3% isoflurane and one or both hind feet were illuminated for 30 min with a 415 nm laser
light source (Prizmatix). The illuminated mice were rested for 4 h before they were infected with ECTV.
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RNA Preparation and RT-qPCR
Total RNA from LNs or sorted cells (104-105 cells) was obtained with the RNeasy Mini Kit (QIAGEN) according to manufacturer’s in-
structions and as previously described (Rubio et al., 2013; Xu et al., 2015). 1 mg of total RNA samples were synthesized with High
Capacity cDNA Reverse Transcription Kit (Life Technologies) according to manufacturer’s instructions. qPCR was performed as
before (Rubio et al., 2013; Xu et al., 2015) using primers as listed in the Key Resources Table. 1 ng of cDNA from each sample
was run in 20 ul reaction using iTaq Universal SYBR Green universal PCR supermix (Bio-Rad). Reactions were performed in a
Bio-Rad CFX96. Ratios of mRNA levels to control values were calculated using the DCt method at a threshold of 0.02. All data
were normalized to control GAPDH. PCR conditions used: hold for 10 min at 95C, followed by 40 cycles of 15 s at 95C and
60 s at 60C.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed with Prism 6 software (GraphPad Software). For survival we used the Log-rank (Mantel-Cox). For other exper-
iments ANOVA with Tukey correction for multiple comparisons or Student’s t test were used as applicable. In all figures, *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.001.
DATA AND CODE AVAILABILITY
This study did not generate any datasets or code.
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